Atrial septal defect percutaneous closure benefits: Difference between revisions

Jump to navigation Jump to search
(New page: {{Template:Atrial septal defect}} {{CMG}} ==Benefits of percutaneous closure== Percutaneous closure is the method of choice in most centers.<!-- --><ref>{{cite journal | author = Bjørn...)
 
m (Bot: Adding CME Category::Cardiology)
 
(22 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{Template:Atrial septal defect}}
{{Atrial septal defect}}
{{CMG}}
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com]; {{CZ}} '''Assistant Editor(s)-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@elon.edu]


==Overview==
==Benefits of percutaneous closure==
==Benefits of percutaneous closure==
Percutaneous closure is the method of choice in most centers.<!--
The percutaneous closure of [[Atrial septal defect ostium secundum|ostium secundum]] is the method of choice in many centers.<ref>{{cite journal | author = Bjørnstad P | title = Is interventional closure the current treatment of choice for selected patients with deficient atrial septation? | journal = Cardiol Young | volume = 16 | issue = 1 | pages = 3-10 | year = 2006 | id = PMID 16454871}}</ref><ref name="pmid10525508">{{cite journal| author=Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A| title=Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. | journal=Heart | year= 1999 | volume= 82 | issue= 5 | pages= 559-62 | pmid=10525508 | doi= | pmc=PMC1760778 | url= }} </ref>. The benefits that can be associated with the closure are as follow:
  --><ref>{{cite journal | author = Bjørnstad P | title = Is interventional closure the current treatment of choice for selected patients with deficient atrial septation? | journal = Cardiol Young | volume = 16 | issue = 1 | pages = 3-10 | year = 2006 | id = PMID 16454871}}</ref> Closure is associated with:
====Disease Related Benefits====
* Fewer complications
 
*Shorter hospital stays
*Fewer complications compared to [[Atrial septal defect surgical closure | surgical closure]].
*Reduced need for blood transfusions
*Reduced need for [[blood transfusion]]s.
*Symptomatic improvement
*Symptomatic improvement.
*Regression of positive airway pressure
*Regression of [[positive airway pressure]].
*Positive changes in right ventricle performance
*Positive changes in right ventricle performance.
*Improved functional capacity
*Improved functional capacity.<ref name="pmid15708694">{{cite journal| author=Salehian O, Horlick E, Schwerzmann M, Haberer K, McLaughlin P, Siu SC et al.| title=Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. | journal=J Am Coll Cardiol | year= 2005 | volume= 45 | issue= 4 | pages= 499-504 | pmid=15708694 | doi=10.1016/j.jacc.2004.10.052 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15708694  }} </ref>
**Improved left atrial volume index
**Improved left atrial volume index.
**Improved left ventricular myocardial performance index
**Improved left ventricular myocardial performance index.
**Improved right ventricular myocardial performance index
**Improved right ventricular myocardial performance index.
**Improved peak oxygen uptake
**Improved peak oxygen uptake.
 
====Other Benefits====
 
* Less invasive no need for [[cardiopulmonary bypass]].
* Successful implantation rates of more than 96%.
* Established practice (done in most hospital these days).
* Cost-effective.
* Shorter hospital stays.


==References==
==References==
{{reflist}}
{{reflist|2}}
 
==See also==
*[[Atrioventricular septal defect]]
*[[Congenital heart disease]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[CME Category::Cardiology]]


[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Congenital heart disease]]
[[Category:Congenital heart disease]]
[[Category:Pediatrics]]
[[Category:Pediatrics]]
 
[[Category:Embryology]]
{{WH}}
[[Category:Disease]]
{{WS}}
[[Category:Mature chapter]]
[[Category:Overview complete]]
[[Category:Up-To-Date]]

Latest revision as of 02:22, 15 March 2016

Atrial Septal Defect Microchapters

Home

Patient Information

Overview

Anatomy

Classification

Ostium Secundum Atrial Septal Defect
Ostium Primum Atrial Septal Defect
Sinus Venosus Atrial Septal Defect
Coronary Sinus
Patent Foramen Ovale
Common or Single Atrium

Pathophysiology

Epidemiology and Demographics

Risk Factors

Natural History and Prognosis

Complications

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Transesophageal Echocardiography
Transthoracic Echocardiography
Contrast Echocardiography
M-Mode
Doppler

Transcranial Doppler Ultrasound

Cardiac Catheterization

Exercise Testing

ACC/AHA Guidelines for Evaluation of Unoperated Patients

Treatment

Medical Therapy

Surgery

Indications for Surgical Repair
Surgical Closure
Minimally Invasive Repair


Robotic ASD Repair
Percutaneous Closure
Post-Surgical Follow Up

Special Scenarios

Pregnancy
Diving and Decompression Sickness
Paradoxical Emboli
Pulmonary Hypertension
Eisenmenger's Syndrome
Atmospheric Pressure

Case Studies

Case #1

Atrial septal defect percutaneous closure benefits On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atrial septal defect percutaneous closure benefits

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrial septal defect percutaneous closure benefits

CDC on Atrial septal defect percutaneous closure benefits

Atrial septal defect percutaneous closure benefits in the news

Blogs on Atrial septal defect percutaneous closure benefits

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Atrial septal defect percutaneous closure benefits

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3] Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]

Overview

Benefits of percutaneous closure

The percutaneous closure of ostium secundum is the method of choice in many centers.[1][2]. The benefits that can be associated with the closure are as follow:

Disease Related Benefits

  • Fewer complications compared to surgical closure.
  • Reduced need for blood transfusions.
  • Symptomatic improvement.
  • Regression of positive airway pressure.
  • Positive changes in right ventricle performance.
  • Improved functional capacity.[3]
    • Improved left atrial volume index.
    • Improved left ventricular myocardial performance index.
    • Improved right ventricular myocardial performance index.
    • Improved peak oxygen uptake.

Other Benefits

  • Less invasive no need for cardiopulmonary bypass.
  • Successful implantation rates of more than 96%.
  • Established practice (done in most hospital these days).
  • Cost-effective.
  • Shorter hospital stays.

References

  1. Bjørnstad P (2006). "Is interventional closure the current treatment of choice for selected patients with deficient atrial septation?". Cardiol Young. 16 (1): 3–10. PMID 16454871.
  2. Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A (1999). "Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder". Heart. 82 (5): 559–62. PMC 1760778. PMID 10525508.
  3. Salehian O, Horlick E, Schwerzmann M, Haberer K, McLaughlin P, Siu SC; et al. (2005). "Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects". J Am Coll Cardiol. 45 (4): 499–504. doi:10.1016/j.jacc.2004.10.052. PMID 15708694.

See also

Template:WikiDoc Sources CME Category::Cardiology